Intuitive Surgical, Inc.

NASDAQ:ISRG

Medical - Devices

Healthcare
$420.95 +0.91%

+$3.65 today

Market cap
$145.92B
Beta
1.45
P/E (TTM)
48.3
EPS (TTM)
$8.39
52W Low $396.68High $603.88

Volume 2.20M

Average 2.21M

ISRG Operating Cash Flow

Cash generated by the company's core business operations during the period.

Intuitive Surgical, Inc.NASDAQ: ISRG

Operating Cash Flow · Q3 FY2026 · quarter ended Sep 2026

Operating cash flow growth accelerates

Q3 FY2026 operating cash flow of $1.22B rose 45.6% year over year, ahead of the +38.1% change in trailing-twelve-month operating cash flow. Sequentially, it rose 15.4% from the prior quarter. Over 3 fiscal years it compounded at +26.7% a year.

Context

  • Operating cash flow amounted to 30.1% of revenue in FY2025, up 1.2 pp from a year earlier.
  • Operating cash flow increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +45.6% holds above the trailing-twelve-month pace of +38.1%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterSep 2026
$1.22B+15.4% QoQ
Last fiscal yearDec 2025
$3.03B+25.5% YoY
LTMSep 2026
$4.09B+38.1% YoY
Operating Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+45.6%——
1 year+25.5%——
3-year CAGR+26.7%——
5-year CAGR——
10-year CAGR——

Operating Cash Flow history

USD · from the cash flow

Latest · FY2025
3.03B USD
Year-over-year change
+25.5%
4-year CAGR
+9.7%

Operating Cash Flow vs competitors

How ISRG compares with its peers on the latest reported figures

  • ISRG's LTM Sep 2026 operating cash flow of $4.09B is the 2nd largest of the 5 companies compared; the peer median is $713.81M.
  • Its year-over-year change of +38.1% is the 2nd highest of 5, against a peer median of +23.1%.
  • Operating cash flow amounts to 35.3% of revenue for ISRG, versus a peer median of 21.1%.
ISRG Competitors Peer median
Operating Cash Flow for ISRG and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SYKStryker CorporationLTM Jun 2026$5.53B +15.9%+24.3%21.4%
ISRGIntuitive Surgical, Inc.LTM Sep 2026$4.09B +38.1%+26.7%35.3%
SNNSmith & Nephew plcFY2025$1.29B +30.2%+40.0%20.8%
CNMDCONMED CorporationLTM Mar 2026$142.63M -20.5%+72.3%10.4%
MBOTMicrobot Medical Inc.LTM Mar 2026$15.23M +64.0%+4.1%14500.0%
Peer median (excluding ISRG) $713.81M+23.1%+32.2%21.1%

Competitors are the stored peer set for ISRG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income1.73B1.34B1.82B2.34B2.88B
Depreciation & Amortization310.2M365.8M454.8M462M677.1M
Deferred Income Tax(62.6M)(185.3M)(280.8M)(135.3M)19.1M
Stock-Based Compensation449.2M513.2M598.2M676.8M788.2M
Change in Working Capital(368.1M)(619.1M)(777.6M)(919.3M)(1.27B)
Accounts Receivables(142.3M)(159.3M)(186.3M)(95.9M)(301.7M)
Inventory(256M)(546.6M)(712.5M)(830M)(1.06B)
Accounts Payables36M21.3M41.7M(400K)57.9M
Other Working Capital(5.8M)65.5M79.5M7M34.9M
Other Non-Cash Items32.6M71.8M1.9M(6.7M)(58.2M)
Operating Cash Flow2.09B1.49B1.81B2.42B3.03B
Capital Expenditures(353.5M)(532.4M)(1.06B)(1.11B)(539.8M)
Acquisitions (Net)(8.7M)(12.8M)(8.9M)(1M)(13.9M)
Purchases of Investments(6.45B)(1.4B)(2.21B)(5.14B)(1.22B)
Sales of Investments4.35B3.32B2.92B2.98B2.44B
Other Investing Activities00000
Investing Cash Flow(2.46B)1.37B(360.1M)(3.27B)665.8M
Debt Repayment00000
Common Stock Issued276.5M0296.3M429.4M350.3M
Common Stock Repurchased0(2.61B)(416.3M)0(2.3B)
Dividends Paid00000
Other Financing Activities(233.5M)(198.7M)(167.6M)(278.5M)(419.1M)
Financing Cash Flow43M(2.57B)(287.6M)150.9M(2.36B)
Effect of Forex Changes(3.4M)5.4M3.3M(800K)12.8M
Net Change in Cash(332.5M)294.7M1.17B(707.7M)1.35B
Free Cash Flow1.74B958.4M749.6M1.3B2.49B

Intuitive Surgical, Inc.

NASDAQ:ISRG

Intrinsic Alpha fair value

Locked

Current Price

$420.95

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.